Abstract:BACKGROUND With the increase of lung cancer screening, more and more patients have been diagnosed as sub-centimeter (≤1 cm) lung adenocarcinoma. Sub-centimeter lung adenocarcinoma is mostly early stage lung cancer, but the research on sub-centimeter lung adenocarcinoma is still insufficient. This study analyzed the clinical characteristics and prognosis of patients with sub-centimeter lung adenocarcinoma in order to provide the basis for the diagnosis and treatment of such patients. METHODS A retrospective study was performed to analyze patients with sub-centimeter lung adenocarcinoma who underwent VATS in Peking University People's Hospital from January 2012 to December 2016. Patients were divided into pure ground-glass nodules (pGGN) group, mixed ground-glass nodules (mGGN) group and solid nodules (SN) group according to the features of nodular imaging. The clinical characteristics of the three groups were compared and the subgroup analysis of nodules in different diameter was performed. We also performed multivariate logistic regression analyses to identify the risk factors for sub-centimeter lung invasive adenocarcinoma. RESULTS The study included 182 patients (57 men and 125 women) with a median age of 54 (27-75) years. Female sub-centimeter lung adenocarcinoma patients had a significantly lower proportion of non-smoking history than males (P<0.001). All patients with 1 mm-10 mm pGGN, 1 mm-5 mm mGGN and 1 mm-5 mm SN had no other pathologically positive findings except for the primary lesion. Of the 46 patients with 6 mm-10 mm mGGN, 3 had pleural invasion and 1 had vascular tumor thrombus. Of the 39 patients with 6 mm-10 mm SN, 5 had pleural invasion, 2 had vascular tumor thrombus and 2 had lymph node metastasis. The pathological type in each patient with pleural invasion, vascular tumor thrombus or lymph node metastasis was invasive adenocarcinoma. Logistic regression analysis indicated that smoking history (OR=4.727, P=0.009), previous tumor history (OR=3.408, P=0.015), mGGN (OR=3.735, P=0.004), SN (OR=8.921, P<0.001) and tumor diameter >5 mm (OR=4.241, P=0.001) were independent risk factors for sub-centimeter lung invasive adenocarcinoma. The median follow-up time was 44 (22-82) months. The 5-year recurrence-free survival rate was 100.0% and the overall survival rate was 98.9%. CONCLUSIONS Patients with sub-centimeter lung adenocarcinoma have a relatively earlier onset age. Sub-centimeter lung invasive adenocarcinoma patients with 6 mm-10 mm mGGN and 6 mm-10 mm SN may be involved in pleural invasion or lymph node metastasis. Smoking history, previous tumor history, mGGN, SN and tumor diameter >5 mm are independent risk factors for sub-centimeter lung invasive adenocarcinoma. For patients with sub-centimeter lung adenocarcinoma, early detection and appropriate surgical intervention can lead to a good prognosis.

Pretreatment Diagnosis and Surgical Management of Minimally Invasive Adenocarcinoma

The IASLC/ATS/ERS Classification of Lung Adenocarcinoma-a Surgical Point of View.

Surgery for Pre- and Minimally Invasive Lung Adenocarcinoma.

[Minimally Invasive Therapies for Early Stage Non-small Cell Lung Cancer].

Clinical Characteristics and Programmed Cell Death Ligand-1 Expression in Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma of Lung

Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section

Evaluation of dynamic image progression of minimally invasive and preinvasive lung adenocarcinomas

Advances on Molecular Mechanism and Clinical Treatment in Invasive Mucinous Adenocarcinoma

Surgical Strategies for Pre- and Minimally Invasive Lung Adenocarcinoma 3.0: Lessons Learned From the Optimal Timing of Surgical Intervention

Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma

Development and validation of a model for predicting upstage in minimally invasive lung adenocarcinoma in Chinese people

Sub-lobar resection versus lobectomy for challenging intraoperative frozen sections in lung adenocarcinoma within 3 cm

Prognostic Effect of Ground-Glass Opacity in Subcentimeter Invasive Lung Adenocarcinoma

Prognostic Significance of the IASLC/ATS/ERS Classification in Chinese Patients—a Single Institution Retrospective Study of 292 Lung Adenocarcinoma

2011 New Lung Adenocarcinoma Multidisciplinary Classification:imaging aspects

Sublobar Resection for Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019): a Study Protocol of Prospective, Single-Arm, Multicenter, Phase III Study

[Shanghai Pulmonary Hospital Experts Consensus on the Management of Ground-Glass Nodules Suspected As Lung Adenocarcinoma (version 1)].

Ground Glass Opacity Resection Extent Assessment Trial (GREAT): A Study Protocol of Multi-Institutional, Prospective, Open-Label, Randomized Phase III Trial of Minimally Invasive Segmentectomy Versus Lobectomy for Ground Glass Opacity (Ggo)-Containing Early-Stage Invasive Lung Adenocarcinoma

Thin-Section Computed Tomography-Histopathologic Comparisons of Pulmonary Focal Interstitial Fibrosis, Atypical Adenomatous Hyperplasia, Adenocarcinoma in Situ, and Minimally Invasive Adenocarcinoma with Pure Ground-Glass Opacity

The Earliest Stage of Lung Adenocarcinoma: the Pathological Diagnosis and Clinical Significance of Adenocarcinoma in Situ

[Clinical Characteristics and Prognosis of Sub-centimeter Lung Adenocarcinoma].